USOR 22041 - Ph2 Epco r/r B-Cell Lymph out pt

A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting (M23-362)

Disease Types: Lymphoma

Available at: Arlington Heights, Niles